基于酸盐的智能catanionic囊泡,用于在瘤微环境中高效地输送多克索鲁比辛
Rui L Machado1,2, Isabel S Oliveira1, Karenina Santos1,2
1CIQUP, IMS, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal. isabel.oliveira@fc.up.pt.
Nanoscale
|November 5, 2025
概括
新的pH敏感的catanionic囊泡显示了癌症治疗的前途. 这些生物相容的纳米载体有效地将诸如多克索鲁比辛 (DOX) 等药物输送到癌细胞中,在低剂量时提高疗效并降低毒性.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 基混合物形成具有可调节性质的自组合聚合物,具有药物输送的潜力.
- 现有的catanionic囊泡往往缺乏有利的细胞毒性,高药物负载和生物活性.
- 开发用于化疗的生物相容和有效的纳米载体仍然是一个重大挑战.
研究的目的:
- 为药物输送应用系统地研究pH敏感的catanionic囊泡.
- 评估新型囊泡配方的细胞毒性,药物负载和释放概况.
- 评估药物载荷囊泡在癌细胞中的"体外"疗效.
主要方法:
- 使用 Lauryl 酸盐 (SLSar) 和阴离子双尾表面活性剂,制备 catanionic 囊泡.
- 囊泡性质的表征,包括大小,表面电荷和体稳定性.
- 细胞毒性查使用L929纤维细胞和 doxorubicin (DOX) 封装和释放研究.
主要成果:
- 在低临界聚合度下,稳定囊泡的自发形成.
- 双子座/SLSar系统在酸性pH下显示出卓越的DOX封装效率和pH敏感释放.
- DOX载荷囊泡的快速细胞吸收和强大的细胞毒性,其度明显低于自由DOX.
结论:
- 基于SLSar的catanionic囊泡代表了一个简单,稳定和可调节的药物输送平台.
- 这些囊泡显示出对响应pH的低剂量癌症化疗的显著潜力.
- 增强的治疗疗效表明,在癌症治疗中可能减少全身毒性.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
130
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
130
Site-Targeted Drug Delivery Systems: Polymeric Carriers
125
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
125


